AngioDynamics Inc
NASDAQ:ANGO

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
NASDAQ:ANGO
Watchlist
Price: 9.19 USD -1.08% Market Closed
Market Cap: 373.2m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ANGO Price Targets Summary
AngioDynamics Inc

Wall Street analysts forecast ANGO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANGO is 15.98 USD with a low forecast of 15.15 USD and a high forecast of 16.8 USD.

ANGO Lowest Forecast
Wall Street Target
15.15 USD
65% Upside
ANGO Average Forecast
Wall Street Target
15.98 USD
74% Upside
ANGO Highest Forecast
Wall Street Target
16.8 USD
83% Upside
Lowest
Price Target
15.15 USD
65% Upside
Average
Price Target
15.98 USD
74% Upside
Highest
Price Target
16.8 USD
83% Upside
AngioDynamics Inc Competitors:
Price Targets
R
REG1V
Revenio Group Oyj
12% Upside
O
226400
Osteonic Co Ltd
37% Upside
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
38% Upside
S
SUS
Surgical Science Sweden AB
42% Upside
R
REG1V
Revenio Group Oyj
12% Upside
O
226400
Osteonic Co Ltd
37% Upside
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
38% Upside
S
SUS
Surgical Science Sweden AB
42% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
4% Upside
M
MYO
Myomo Inc
99% Upside
GEHC
GE Healthcare Technologies Inc
47% Upside
O
OBI
Ondine Biomedical Inc
523% Upside

Revenue
Forecast

Revenue Estimate
AngioDynamics Inc

For the last 8 years the compound annual growth rate for AngioDynamics Inc's revenue is -2%. The projected CAGR for the next 3 years is 3%.

-2%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
AngioDynamics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
AngioDynamics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ANGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANGO stock valuation using valuation multiples.
Wall Street Estimates
ANGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANGO's stock price target?
Price Target
15.98 USD

According to Wall Street analysts, the average 1-year price target for ANGO is 15.98 USD with a low forecast of 15.15 USD and a high forecast of 16.8 USD.

What is AngioDynamics Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for AngioDynamics Inc's revenue is -2%. The projected CAGR for the next 3 years is 3%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.